BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 21081044)

  • 21. Expression of TSLC1, a candidate tumor suppressor gene mapped to chromosome 11q23, is downregulated in unfavorable neuroblastoma without promoter hypermethylation.
    Ando K; Ohira M; Ozaki T; Nakagawa A; Akazawa K; Suenaga Y; Nakamura Y; Koda T; Kamijo T; Murakami Y; Nakagawara A
    Int J Cancer; 2008 Nov; 123(9):2087-94. PubMed ID: 18726896
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Loss/Down-regulation of tumor suppressor in lung cancer 1 expression is associated with tumor progression and is a biomarker of poor prognosis in ovarian carcinoma.
    Yang G; He W; Cai M; Luo F; Kung H; Guan X; Zeng Y; Xie D
    Int J Gynecol Cancer; 2011 Apr; 21(3):486-93. PubMed ID: 21436696
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hypermethylation of the TSLC1/IGSF4 promoter is associated with tobacco smoking and a poor prognosis in primary nonsmall cell lung carcinoma.
    Kikuchi S; Yamada D; Fukami T; Maruyama T; Ito A; Asamura H; Matsuno Y; Onizuka M; Murakami Y
    Cancer; 2006 Apr; 106(8):1751-8. PubMed ID: 16534787
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Association of a lung tumor suppressor TSLC1 with MPP3, a human homologue of Drosophila tumor suppressor Dlg.
    Fukuhara H; Masuda M; Yageta M; Fukami T; Kuramochi M; Maruyama T; Kitamura T; Murakami Y
    Oncogene; 2003 Sep; 22(40):6160-5. PubMed ID: 13679854
    [TBL] [Abstract][Full Text] [Related]  

  • 25. CADM1/TSLC1 inactivation by promoter hypermethylation is a frequent event in colorectal carcinogenesis and correlates with late stages of the disease.
    Chen K; Wang G; Peng L; Liu S; Fu X; Zhou Y; Yu H; Li A; Li J; Zhang S; Bai Y; Zhang Y
    Int J Cancer; 2011 Jan; 128(2):266-73. PubMed ID: 20340131
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Disruption of spermatogenic cell adhesion and male infertility in mice lacking TSLC1/IGSF4, an immunoglobulin superfamily cell adhesion molecule.
    Yamada D; Yoshida M; Williams YN; Fukami T; Kikuchi S; Masuda M; Maruyama T; Ohta T; Nakae D; Maekawa A; Kitamura T; Murakami Y
    Mol Cell Biol; 2006 May; 26(9):3610-24. PubMed ID: 16612000
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Involvement of tumor suppressor in lung cancer 1 gene expression in cervical carcinogenesis.
    Yang YX; Yang AH; Yang ZJ; Wang ZR; Xia XH
    Int J Gynecol Cancer; 2006; 16(5):1868-72. PubMed ID: 17009984
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Reduced expression of the Tslc1 gene and its aberrant DNA methylation in rat lung tumors.
    Shimizu K; Itsuzaki Y; Onishi M; Fujii H; Honoki K; Tsujiuchi T
    Biochem Biophys Res Commun; 2006 Aug; 347(1):358-62. PubMed ID: 16814249
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Loss of tumor suppressor in lung cancer-1 (TSLC1) expression in meningioma correlates with increased malignancy grade and reduced patient survival.
    Surace EI; Lusis E; Murakami Y; Scheithauer BW; Perry A; Gutmann DH
    J Neuropathol Exp Neurol; 2004 Oct; 63(10):1015-27. PubMed ID: 15535129
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The minimal Tumor Suppressor in Lung Cancer-1 promoter is restrained by an inhibitory region.
    Hori RT
    Mol Biol Rep; 2010 Apr; 37(4):1979-85. PubMed ID: 19653122
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Significance of TSLC1 gene methylation and TSLC1 protein expression in the progression of cervical lesions].
    Zhao X; Cui Y; Li Y; Liang S; Zhang Y; Xie L; Xia Z; Du J; Wei L; Li Y
    Zhonghua Zhong Liu Za Zhi; 2015 May; 37(5):356-60. PubMed ID: 26463026
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical implication and prognostic significance of the tumor suppressor TSLC1 gene detected in adenocarcinoma of the lung.
    Uchino K; Ito A; Wakayama T; Koma Y; Okada T; Ohbayashi C; Iseki S; Kitamura Y; Tsubota N; Okita Y; Okada M
    Cancer; 2003 Sep; 98(5):1002-7. PubMed ID: 12942568
    [TBL] [Abstract][Full Text] [Related]  

  • 33. LncRNA TSLC1-AS1 is a novel tumor suppressor in glioma.
    Qin X; Yao J; Geng P; Fu X; Xue J; Zhang Z
    Int J Clin Exp Pathol; 2014; 7(6):3065-72. PubMed ID: 25031725
    [TBL] [Abstract][Full Text] [Related]  

  • 34. TSLC1 is a tumor-suppressor gene in human non-small-cell lung cancer.
    Kuramochi M; Fukuhara H; Nobukuni T; Kanbe T; Maruyama T; Ghosh HP; Pletcher M; Isomura M; Onizuka M; Kitamura T; Sekiya T; Reeves RH; Murakami Y
    Nat Genet; 2001 Apr; 27(4):427-30. PubMed ID: 11279526
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tumor suppressor in lung cancer (TSLC)1 suppresses epithelial cell scattering and tubulogenesis.
    Masuda M; Kikuchi S; Maruyama T; Sakurai-Yageta M; Williams YN; Ghosh HP; Murakami Y
    J Biol Chem; 2005 Dec; 280(51):42164-71. PubMed ID: 16223734
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Oligo-astheno-teratozoospermia in mice lacking RA175/TSLC1/SynCAM/IGSF4A, a cell adhesion molecule in the immunoglobulin superfamily.
    Fujita E; Kouroku Y; Ozeki S; Tanabe Y; Toyama Y; Maekawa M; Kojima N; Senoo H; Toshimori K; Momoi T
    Mol Cell Biol; 2006 Jan; 26(2):718-26. PubMed ID: 16382161
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Downregulation of TSLC1 and DAL-1 expression occurs frequently in breast cancer.
    Heller G; Geradts J; Ziegler B; Newsham I; Filipits M; Markis-Ritzinger EM; Kandioler D; Berger W; Stiglbauer W; Depisch D; Pirker R; Zielinski CC; Zöchbauer-Müller S
    Breast Cancer Res Treat; 2007 Jul; 103(3):283-91. PubMed ID: 17260099
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Expression of the tumor suppressor genes NF2, 4.1B, and TSLC1 in canine meningiomas.
    Dickinson PJ; Surace EI; Cambell M; Higgins RJ; Leutenegger CM; Bollen AW; LeCouteur RA; Gutmann DH
    Vet Pathol; 2009 Sep; 46(5):884-92. PubMed ID: 19429976
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tumor suppressor in lung cancer 1 gene expression in epithelial ovarian cancer.
    Qu H; Xu F; Bai Y; Si X; Yang A
    Indian J Cancer; 2016; 53(1):8-11. PubMed ID: 27146728
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Aberrant methylation of the 5' CpG island of TSLC1 is common in pancreatic ductal adenocarcinoma and is first manifest in high-grade PanlNs.
    Jansen M; Fukushima N; Rosty C; Walter K; Altink R; Heek TV; Hruban R; Offerhaus JG; Goggins M
    Cancer Biol Ther; 2002; 1(3):293-6. PubMed ID: 12432281
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.